Don't disregard the threat of MenB Although meningococcal disease is uncommon, it can progress quickly. In fact, it can lead to death.4 Get the Facts Complete your patients' MenB series using a vaccine with nearly a decade of experience BEXSERO has a 2-dose schedule for every appropriate ...
Although meningococcal disease is uncommon, it can progress quickly. In fact, it can lead to death.4 Get the Facts Complete your patients' MenB series using a vaccine with nearly a decade of experience BEXSERO has a 2-dose schedule for every appropriate patient who follows the 6-month interv...
young adults demonstrated that MenB-FHbp, a meningococcal serogroup B (MenB) vaccine, elicits protective immune responses after 2 or 3 doses based on serum bactericidal antibody assays using human complement (hSBA) against 4 primary and 10 additional diverse, vaccine-heterologous MenB test strains...
MenQuadfi is approved for use in individuals 2 years of age and older. MenQuadfi does not prevent N meningitidis serogroup B disease.1 MenQuadfi is a solution that does not require reconstitution and will allow you to reimagine how you can help protect against meningococcal disease.1...
MenQuadfi is a vaccineindicated for active immunization for the prevention of invasive meningococcal diseasecaused byNeisseria meningitidisserogroups A, C, W, and Y. MenQuadfi is approved for use in individuals 2 years of age and older. MenQuadfi does not preventN meningitidisserogroup B disease...
NmB disease isolates (collected in 2000 to 2008) that were selected by the Active Bacterial Core Surveillance (ABCs; CDC) laboratory that are representative of serogroup B meningococcal disease in the United States (26). MATS analysis was performed on each NmB isolate, and the results were ...
The meningococcal antigen typing system (MATS) is an enzyme-linked immunosorbent assay (ELISA)-based system that assesses the levels of expression and immune reactivity of the three recombinant MenB-4C antigens and, in conjunction with PorA variable 2 (VR2) sequencing, provides an estimate of ...
Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 Years Bivalent rLP2086 vaccine (Trumenba(R)): a review in active immunization against invasive meningococcal group B disease in individuals aged 10-25 yea...
Men who have sex with men (MSM) comprise a heterogeneous group of men with diverse sexual behaviors and who have a high burden of sexually transmitted infections (STI). Among MSM, HIV-infected MSM are most affected by STI. Biological, behavioral, and societal factors contribute to these high...
Paediatric meningococcemia in Northwestern Ontario, Canada: a case for publicly funded meningococcal B vaccination R Tsang,V Eton,M Ulanova 被引量: 0发表: 2015年 Chronic meningococcaemia: a case report Chronic meningococcaemia (CM), caused by the bacterium Neisseria meningitidis is reported ...